compartir en facebook Compartir en Twitter compartir en Linkedin

Enfermedades infecciosas

Grupo Infecciosas

Publicaciones GT Enfermedades infecciosas 2021

Listado de publicaciones del registro SEMI-COVID-19

  1. Carrasco-Sánchez FJ, López-Carmona MD, Martínez-Marcos FJ, et al. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with  COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19  Registry. Ann Med. 2021;53(1):103-116. doi:10.1080/07853890.2020.1836566
  2. Formiga F, Rubio-Rivas M, Mora-Luján JM, et al. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry. Intern Emerg Med. Published online November 29, 2021:1-15. doi:10.1007/s11739-021-02870-1
  3. Salinas-Botrán A, Pérez-Belmonte LM, Méndez-Bailón M. Respuesta a la carta Tratamiento con glucocorticoides en pacientes con COVID-19 e insuficiencia cardíaca concurrente. Revista Clínica Española. Published online November 20, 2021. doi:10.1016/j.rce.2021.11.001
  4. Navas Alcántara MS, Montero Rivas L, Guisado Espartero ME, et al. Influence of smoking history on the evolution of hospitalized in COVID-19 positive patients: results from the SEMI-COVID-19 registry. Med Clin (Barc). Published online November 15, 2021:S0025-7753(21)00650-3. doi:10.1016/j.medcli.2021.10.011
  5. Bendala Estrada AD, Calderón Parra J, Fernández Carracedo E, et al. Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy. BMC Infect Dis. 2021;21(1):1144. doi:10.1186/s12879-021-06821-1
  6. Navas Alcántara MS, Montero Rivas L, Guisado Espartero ME, et al. Influencia de la historia de tabaquismo en la evolución de la hospitalización en pacientes COVID-19 positivos: datos del registro SEMI-COVID-19. Medicina Clínica. Published online November 2021:S0025775321006503. doi:10.1016/j.medcli.2021.10.011
  7. Rubio-Rivas M, Mora-Luján JM, Montero A, et al. The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers. J Gen Intern Med. Published online October 18, 2021. doi:10.1007/s11606-021-07146-0
  8. Muñoz-Gómez A, Fernández-Cruz A, Lavilla-Olleros C, et al. Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective Study. J Clin Med. 2021;10(20):4678. doi:10.3390/jcm10204678
  9. Pérez-Belmonte LM, Sanz-Cánovas J, Salinas A, et al. Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study. Intern Emerg Med. Published online October 12, 2021. doi:10.1007/s11739-021-02843-4
  10. Ramos-Rincón JM, Bernabeu-Whittel M, Fiteni-Mera I, et al. Clinical features and risk factors for mortality among long-term care facility residents hospitalized due to COVID-19 in Spain. J Gerontol A Biol Sci Med Sci. Published online October 9, 2021:glab305. doi:10.1093/gerona/glab305
  11. Luis M. Pérez-Belmonte, Jaime Sanz-Cánovas, Alejandro Salinas, Jose Luis Garcia-Klepzig, Manuel Méndez-Bailón, Ricardo Gómez-Huelgas. Adverse outcomes in patients with heart failure admitted for COVID-19 in association with renin-angiotensin-aldosterone system inhibitors. Polish Archives of Internal Medicine. Published online October 2021. doi:10.20452/pamw.16126
  12. Díaz-Simón R, Lalueza A, Lora-Tamayo J, et al. Clinical Characteristics and Risk Factors of Respiratory Failure in a Cohort of Young Patients Requiring Hospital Admission with SARS-CoV2 Infection in Spain:  Results of the Multicenter SEMI-COVID-19 Registry. J Gen Intern Med. Published online August 11, 2021:1-8. doi:10.1007/s11606-021-07066-z
  13. Suárez-García I, Perales-Fraile I, González-García A, et al. In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain. PLOS ONE. 2021;16(8):e0255524. doi:10.1371/journal.pone.0255524
  14. García-Cervera C, Giner-Galvañ V, Wikman-Jorgensen P, et al. Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry. J Gen Intern Med. Published online July 21, 2021:1-9. doi:10.1007/s11606-021-07017-8
  15. Salinas-Botrán A, Sanz-Cánovas J, Pérez-Somarriba J, et al. [Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain]. Rev Clin Esp. Published online July 17, 2021. doi:10.1016/j.rce.2021.06.004
  16. Martinez-Lacalzada M, Viteri-Noël A, Manzano L, et al. Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables: development and validation of the PRIORITY  model. Clin Microbiol Infect. Published online July 15, 2021. doi:10.1016/j.cmi.2021.07.006
  17. Ramos-Martínez A, Parra-Ramírez LM, Morrás I, et al. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients. Sci Rep. 2021;11(1):13733. doi:10.1038/s41598-021-93076-0
  18. Ena J, Vicente Segura-Heras J, Fonseca-Aizpuru EM, et al. [Derivation and validation of a risk score for admission to the intensive care unit in patients with COVID-19]. Rev Clin Esp. Published online June 23, 2021. doi:10.1016/j.rce.2021.06.003
  19. Loureiro-Amigo J, Suárez-Carantoña C, Oriol-Bermúdez I, et al. Prone Position in COVID-19 Patients With Severe Acute Respiratory Distress Syndrome Receiving Conventional Oxygen Therapy: A Retrospective Study. Archivos de Bronconeumología. Published online June 6, 2021. doi:10.1016/j.arbres.2021.05.018
  20. Martos Pérez F, Gomez Huelgas R, Martín Escalante MD, Casas Rojo JM. Minimizing Selection and Classification Biases. Comment on “Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing.” J Med Internet Res. Published online May 13, 2021. doi:10.2196/27142
  21. Calderón-Parra J, Muiño-Miguez A, Bendala-Estrada AD, et al. Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLOS ONE. 2021;16(5):e0251340. doi:10.1371/journal.pone.0251340
  22. Ramos-Rincón JM, Pérez-Belmonte LM, Carrasco-Sánchez FJ, et al. Cardiometabolic therapy and mortality in very old patients with diabetes hospitalized due to COVID-19. J Gerontol A Biol Sci Med Sci. Published online May 4, 2021. doi:10.1093/gerona/glab124
  23. Ayala Gutiérrez MDM, Rubio-Rivas M, Romero Gómez C, et al. Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry. J Clin Med. 2021;10(9):1844. doi:10.3390/jcm10091844
  24. Rodilla E, Saura A, Jiménez I, et al. ASSOCIATION OF HYPERTENSION WITH ALL-CAUSE MORTALITY AMONG HOSPITALIZED PATIENTS WITH COVID-19. Journal of Hypertension. 2021;39:e37. doi:10.1097/01.hjh.0000744744.89609.0d
  25. Rodilla E, Belda A, Canales S, et al. ASSOCIATION OF ARTERIAL STIFFNESS WITH ALL-CAUSE MORTALITY AMONG HOSPITALIZED COVID-19 PATIENTS. Journal of Hypertension. 2021;39:e202. doi:10.1097/01.hjh.0000746720.89890.ca
  26. Torres-Peña JD, Pérez-Belmonte LM, Fuentes-Jiménez F, et al. Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry. Drugs. Published online March 29, 2021:1-11. doi:10.1007/s40265-021-01498-x
  27. Lora-Tamayo J, Maestro G, Lalueza A, et al. Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: results of a large multicenter study. Journal of Infection. 2021;0(0):S0163-4453(21)00077-3. doi:10.1016/j.jinf.2021.02.011
  28. Artero A, Madrazo M, Fernández-Garcés M, et al. Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study. J Gen Intern Med. Published online February 11, 2021:1-8. doi:10.1007/s11606-021-06626-7
  29. Antúnez MG, Míguez AM, Estrada ADB, et al. Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2. Int J Chron Obstruct Pulmon Dis. 2021;15:3433-3445. doi:10.2147/COPD.S276692
  30. Rubio-Rivas M, Corbella X, Formiga F, et al. Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 Registry. J Clin Med. 2021;10(10):2214. doi:10.3390/jcm10102214
  31. Josa-Laorden C, Crestelo-Vieitez A, García Andreu M del M, et al. Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study. Journal of Clinical Medicine. 2021;10(5):899. doi:10.3390/jcm10050899
  32. Balaz D, Wikman-Jorgensen PE, Galvañ VG, et al. Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry. J Clin Med. 2021;10(19):4610. doi:10.3390/jcm10194610
  33. Roy-Vallejo E, Sánchez Purificación A, Torres Peña JD, et al. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19. Journal of Clinical Medicine. 2021;10(12). doi:10.3390/jcm10122642
  34. Olalla-Sierra J, Martín-Escalante MD, García-Alegría J, et al. Covid-19 hospitalization outcomes in persons with and without HIV in SPAIN: the Semi-Covid-19 registry. AIDS. Published online 2021. doi:10.1097/QAD.0000000000003056
  35. Mateos González M, Sierra Gonzalo E, Casado Lopez I, et al. The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals. Journal of Clinical Medicine. 2021;10(2):305. doi:10.3390/jcm10020305
  36. Díez-Manglano J, Solís-Marquínez MN, Álvarez García A, et al. Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry. PLoS One. 2021;16(2):e0247422. doi:10.1371/journal.pone.0247422
  37. Rodilla E, Lopez-Carmona MD, Cortes X, et al. Impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain. Hypertension. 2020;77(3):856-867. doi:10.1161/HYPERTENSIONAHA.120.16563
  38. Pérez-Belmonte LM, Torres-Peña JD, López-Carmona MD, et al. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus  admitted for COVID-19 in association with glucose-lowering drugs: a nationwide  cohort study. BMC Med. 2020;18(1):359. doi:10.1186/s12916-020-01832-2
  39. Bernabeu-Wittel M, Gómez-Huelgas R, Nieto-Martín MD. Time to Stop the Tragedy in Spanish Nursing Homes during the COVID-19 Pandemic. J Am Geriatr Soc. 2020;69(2):320-322. doi:10.1111/jgs.16943
  40. Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results  from the SEMI-COVID-19 Registry. Rev Clin Esp. 2020;220(8):480-494. doi:10.1016/j.rceng.2020.07.003
  41. Rubio-Rivas M, Corbella X, Mora-Luján JM, et al. Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An  Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19. J Clin Med. 2020;9(11):3488. doi:10.3390/jcm9113488
  42. Ramos-Rincon JM, Buonaiuto V, Ricci M, et al. Clinical Characteristics and Risk Factors for Mortality in Very Old Patients  Hospitalized with COVID-19 in Spain. J Gerontol A Biol Sci Med Sci. 2020;76(3):e28-e37. doi:10.1093/gerona/glaa243
  43. Rodilla E, Saura A, Jiménez I, et al. Association of Hypertension with All-Cause Mortality among Hospitalized Patients  with COVID-19. J Clin Med. 2020;9(10):3136. doi:10.3390/jcm9103136

Publicaciones del grupo pero no relacionadas con Covid

1. Collazos J, de la Fuente B, García A, Gómez H, Menéndez C, Enríquez H, Sánchez P, Alonso M, López-Cruz I, Martín-Regidor M, Martínez-Alonso A, Guerra J, Artero A, Blanes M, de la Fuente J, Asensi V. Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment. PLoS One. 2018 Sep 27;13(9):e0204036

2. Collazos J, de la Fuente B, de la Fuente J, García A, Gómez H, Menéndez C, Enríquez H, Sánchez P, Alonso M, López-Cruz I, Martín-Regidor M, Martínez-Alonso A, Guerra J, Artero A, Blanes M, Asensi V. Factors associated with sepsis development in 606 Spanish adult patients with cellulitis. BMC Infect Dis. 2020 Mar 12;20(1):211.

3. Collazos J, de la Fuente B, de la Fuente J, García A, Gómez H, Rivas-Carmenado M, Suárez-Zarracina T, García-Carús E, Suárez-Diaz S, Enríquez H, Sánchez P, Alonso M, López-Cruz I, Martín-Regidor M, Martínez-Alonso A, Guerra J, Artero A, Blanes M, Asensi V. Sex differences in hospitalized adult patients with cellulitis: A prospective, multicenter study. Int J Infect Dis. 2021 Mar;104:584-591

4. Collazos J, Domingo P, Fernández-Araujo N, Asensi-Díaz E, Vilchez-Rueda H, Lalueza A, Roy-Vallejo E, Blanes R, Raya-Cruz M, Sanz-Cánovas J, Artero A, Ramos-Rincón JM, Dueñas-Gutiérrez C, Lamas-Ferreiro JL, Asensi V; Valproic Acid in COVID-19 Study Group. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19. PLoS One. 2022 Jan 27;17(1):e0262777

Año de publicación: 
2021